Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Austin G Kulasekararaj

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
British Journal of Haematology|June 26, 2020
Regulatory cells in immune-mediated aplastic anaemia - not T<sub>regs</sub> but B<sub>regs</sub>Austin G Kulasekararaj
British Journal of Haematology|March 16, 2017
Clonal dominance of PNH- another piece to the jigsawAustin G Kulasekararaj
Blood|April 27, 2023
AI for AA: machine learning makes an entryAustin G Kulasekararaj
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 10, 2020
Second-Generation C5 Inhibitors for Paroxysmal Nocturnal HemoglobinuriaBruno Fattizzo, Austin G Kulasekararaj
Haematologica|April 14, 2022
A tribute to Fanconi: 'clinical acumen still counts'Austin G Kulasekararaj, Shreyans Gandhi
British Journal of Haematology|May 16, 2021
Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19: responseHenry Wood, Austin G Kulasekararaj
American Journal of Hematology|February 16, 2023
Paroxysmal nocturnal hemoglobinuria: Where are we goingAustin G Kulasekararaj, Ioanna Lazana
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2023
Eltrombopag in Lower-Risk Myelodysplastic Syndrome: Revival of Its Use in ThrombocytopeniaAustin G Kulasekararaj, Roochi Trikha
Blood Advances|August 27, 2024
Consensus recommendations for severe aplastic anemiaPhillip Scheinberg, Austin G Kulasekararaj
Expert Opinion on Biological Therapy|February 4, 2020
Ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuriaJong Wook Lee, Austin G Kulasekararaj
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|June 26, 2020
Regulatory cells in immune-mediated aplastic anaemia - not T<sub>regs</sub> but B<sub>regs</sub>Austin G Kulasekararaj
British Journal of Haematology|March 16, 2017
Clonal dominance of PNH- another piece to the jigsawAustin G Kulasekararaj
Blood|April 27, 2023
AI for AA: machine learning makes an entryAustin G Kulasekararaj
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 10, 2020
Second-Generation C5 Inhibitors for Paroxysmal Nocturnal HemoglobinuriaBruno Fattizzo, Austin G Kulasekararaj
Haematologica|April 14, 2022
A tribute to Fanconi: 'clinical acumen still counts'Austin G Kulasekararaj, Shreyans Gandhi
British Journal of Haematology|May 16, 2021
Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19: responseHenry Wood, Austin G Kulasekararaj
American Journal of Hematology|February 16, 2023
Paroxysmal nocturnal hemoglobinuria: Where are we goingAustin G Kulasekararaj, Ioanna Lazana
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2023
Eltrombopag in Lower-Risk Myelodysplastic Syndrome: Revival of Its Use in ThrombocytopeniaAustin G Kulasekararaj, Roochi Trikha
Blood Advances|August 27, 2024
Consensus recommendations for severe aplastic anemiaPhillip Scheinberg, Austin G Kulasekararaj
Expert Opinion on Biological Therapy|February 4, 2020
Ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuriaJong Wook Lee, Austin G Kulasekararaj
Pageof 11